Home / Diphtheria-Pertussis-Poliomyelitis-Tetanus / Norway
NO ATC J07CA02 · updated 2 Nov 2026
Diphtheria-Pertussis-Poliomyelitis-Tetanus shortage in Norway
Is there a Diphtheria-Pertussis-Poliomyelitis-Tetanus shortage in Norway?
Yes. As of 2 Nov 2026, 1 Diphtheria-Pertussis-Poliomyelitis-Tetanus product is reported short in Norway. The company estimate for the return is 18 Jan 2027. Main reason: increased demand.
Also short in Italy, Belgium, Switzerland. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Boostrix Polio injeksjonsvæske, suspensjon i ferdigfylt sprøyte, 0 ml ferdigfylt sprøyte av glass anticipated | GlaxoSmithKline AS | 22 Dec 2026 | 18 Jan 2027 | Increased demand Uventet økt etterspørsel |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).